Lactic acid bacteria powder packaging products

Abstract

A lactic acid bacteria powder packaged product is provided, which includes a packaging bag and lactic acid bacteria powder. [Solution] The packaging bag 1 has two seal structures 11 and a closed space 100 located between the two seal structures, and the lactic acid bacteria powder 2 is contained in the closed space. When in use, the seal structure of the packaging bag is broken and the powder is taken through the spout.

Description

[Technical Field]

[0001] The present invention relates to a powder packaging product, and in particular to a lactic acid bacteria powder packaging product. [Background technology]

[0002] As we age, we begin to experience a variety of internal and external physiological problems, such as gastrointestinal indigestion, constipation, seasonal allergies, rough skin, and a pale complexion. Research has found that these symptoms may be linked to an imbalance in the gut microbiome.

[0003] In addition to the effects of aging, factors such as lack of exercise, excessive stress in modern society, and an irregular and unbalanced diet also accelerate the loss of beneficial bacteria in the intestinal flora. Therefore, maintaining a balance in the intestinal flora is extremely important for the health of all people, and what is particularly important is whether the strains of bacteria are beneficial to human health and whether the number of bacteria is sufficient to maintain the balance between beneficial and harmful bacteria in the intestinal flora.

[0004] Therefore, one of the key challenges is how to develop new formulations and packaging structures of lactic acid bacteria to provide specific strains and sufficient amounts of bacteria to stabilize the growth of beneficial intestinal flora and promote healthy digestive function. Summary of the Invention [Problem to be solved by the invention]

[0005] The technical problem that this invention aims to solve is to provide a lactic acid bacteria powder packaged product to address the shortcomings of the prior art. [Means for solving the problem]

[0006] To solve the above technical problems, one of the technical solutions adopted by the present invention is to provide a lactic acid bacteria powder packaging product comprising a packaging bag and lactic acid bacteria powder, the packaging bag having two sealing structures and a closed space located between the two sealing structures, and the lactic acid bacteria powder contained in the closed space.

[0007] In a possible or preferred embodiment of the present invention, the lactic acid bacteria powder blend comprises Lacticaseibacillus paracasei, Bifidobacterium longum, Lactobacillus crispatus, and Lactobacillus helveticus.

[0008] In a possible or preferred embodiment of the present invention, the range of the number of bacteria in the lactic acid bacteria powder is 100 billion to 200 billion.

[0009] In a possible or preferred embodiment of the present invention, the dosage range of the lactic acid bacteria powder is 1.5g (grams) to 3g.

[0010] In a possible or preferred embodiment of the present invention, the blend of lactic acid bacteria powder is a heat-treated lactic acid bacteria powder.

[0011] In a possible or preferred embodiment of the present invention, the range of bacterial count of the Lacticaseibacillus paracasei is 100 billion to 200 billion, the range of bacterial count of the Bifidobacterium longum is 6 billion to 12 billion, the range of bacterial count of the Lactobacillus crispatus is 10 billion to 20 billion, and the range of bacterial count of the Lactobacillus helveticus is 500 million to 1 billion.

[0012] In a possible or preferred embodiment of the present invention, the formulation of the lactic acid bacteria powder comprises at least one functional ingredient.

[0013] In a possible or preferred embodiment of the present invention, the at least one functional ingredient is at least one of fructooligosaccharides, inulin, corn starch, maltodextrin, calcium stearate, and silicon dioxide ingredients.

[0014] In a possible or preferred embodiment of the present invention, the dosage range of the fructooligosaccharides is 530 mg (milligrams) to 1060 mg.

[0015] In a possible or preferred embodiment of the present invention, the packaging bag is a stick packaging bag.

[0016] In a possible or preferred embodiment of the present invention, one of the two sealing structures is provided with a tear line.

[0017] In a possible or preferred embodiment of the present invention, the packaging bag is made of an aluminum foil composite structure.

[0018] In a possible or preferred embodiment of the present invention, the aluminum foil composite structure includes an outer layer, an inner layer, and an intermediate layer located between the outer layer and the inner layer, and the material of the intermediate layer is aluminum foil. [Effects of the Invention]

[0019] Overall, the lactic acid bacteria powder packaged product of the present invention is lightweight, space-saving, and portable, and the lactic acid bacteria powder can be taken by simply breaking one of the seals on the packaging bag.Furthermore, the lactic acid bacteria powder packaged product of the present invention has significant effects on improving digestion, maintaining the balance of beneficial intestinal flora, and promoting human health. [Brief explanation of the drawings]

[0020] [Figure 1] 1 is a schematic diagram showing the structure of a lactic acid bacteria powder packaged product according to the present invention. [Figure 2] 1 is a schematic diagram showing another structure of the lactic acid bacteria powder packaged product of the present invention. [Figure 3] 1 is a schematic diagram showing the use of the lactic acid bacteria powder packaged product of the present invention. [Figure 4] 1 is a schematic diagram showing the aluminum foil composite structure of the packaging bag of the lactic acid bacteria powder packaged product of the present invention. DETAILED DESCRIPTION OF THE INVENTION

[0021] To better understand the features and technical contents of the present invention, please refer to the following detailed description of the present invention and the drawings, which are for reference and explanation only and are not intended to limit the present invention.

[0022] The following describes the implementation of the "packaged lactic acid bacteria powder product" according to the present invention through specific embodiments, and those skilled in the art can understand the advantages and effects of the present invention based on the content disclosed herein. The present invention can be implemented or applied in other different specific embodiments, and various modifications and changes can be made to the details herein based on different perspectives and applications without departing from the concept of the present invention. It should be noted in advance that the accompanying drawings of the present invention are for simple schematic illustrations and are not drawn to actual size. The technical content of the present invention will be described in more detail based on the following embodiments, but the disclosed content does not limit the scope of protection of the present invention.

[0023] It should be understood that although the present specification may use terms such as "first," "second," and "third" to describe various elements or signals, these elements or signals are not limited by these terms. These terms are primarily used to distinguish one element from another element or one signal from another signal. Furthermore, the term "or" used in the present specification may include any one or more combinations of the associated listed items, depending on the actual situation.

[0024] As shown in Figures 1 to 3, Figures 1 and 2 show the structure of a lactic acid bacteria powder packaged product Z according to an embodiment of the present invention, and Figure 3 shows how to use the lactic acid bacteria powder packaged product Z. As shown in Figure 1, the lactic acid bacteria powder packaged product Z includes a packaging bag 1 and lactic acid bacteria powder 2. The packaging bag 1 has two seal structures 11, 12 and a closed space 100 located between the two seal structures 11, 12, and the lactic acid bacteria powder 2 is contained in the closed space 100. As shown in Figure 3, when in use, simply by breaking one of the seal structures, seal structure 11, of the packaging bag 1, to form a spout 11', the lactic acid bacteria powder 2 in the closed space 100 can be taken out through the spout 11' and consumed.

[0025] In actual application, the packaging bag 1 may be a stick packaging bag, as shown in Figures 2 and 3. The sealing structure 11 of the packaging bag 1 has a tear line 11L so that the user can easily break the sealing structure 11 of the packaging bag 1 and remove the lactic acid bacteria powder 2. Specifically, the tear line 11L is a structurally weak portion formed by mechanical processing or laser processing, and may be formed in a straight line, but is not limited thereto. In an embodiment not shown, the tear line 11L may be formed in an arc or wavy line.

[0026] As shown in Figure 4, the packaging bag 1 is formed with an aluminum foil composite structure. Specifically, the aluminum foil composite structure may include an outer layer 111, an inner layer 113, and an intermediate layer 112 located between the outer layer 111 and the inner layer 113. The outer layer 111 may be made of a material such as polyester PET that has high mechanical strength and abrasion resistance and is suitable for printing. The intermediate layer 112 may be made of an opaque material such as aluminum foil. The inner layer 113 may be made of a material that meets food safety standards, such as polyethylene or polypropylene. However, the above example is merely one possible embodiment, and the present invention is not limited thereto.

[0027] In the present invention, the lactic acid bacteria powder 2 mainly includes Lactobacillus paracasei, Bifidobacterium longum, Lactobacillus crispatus, and Lactobacillus helveticus. Furthermore, the dosage range of the lactic acid bacteria powder 2 can be 1.5g (grams) to 3g. However, the above example is merely one embodiment, and the present invention is not limited thereto.

[0028] Specifically, in order to supply sufficient probiotics to the intestines, the range of bacterial count in the lactic acid bacteria powder 2 can be 100 billion to 200 billion. Furthermore, the lactic acid bacteria powder 2 may be a heat-treated lactic acid bacteria powder. Specifically, lactic acid bacteria that have been inactivated by heat (heat-treated lactic acid bacteria) have improved heat resistance, so there is no need to worry about a decrease in bacterial count even in relatively high water temperatures. They are also resistant to degradation by gastric acid, and can reach the intestines after being digested by gastric acid, where they can function stably.

[0029] In this embodiment, the lactic acid bacteria powder 2 contains Lactobacillus paracasei K-2, Bifidobacterium longum KMH001, Lactobacillus crispatus KT-11, Bifidobacterium longum BR-108, and Lactobacillus helveticus MCC1848. That is, the lactic acid bacteria powder 2 of the present invention may be a combination of specific lactic acid bacteria strains. Specifically, in this embodiment, the bacterial count range of Lacticaseibacillus paracasei K-2 is 100 billion to 200 billion, the bacterial count range of Lactobacillus crispatus KT-11 is 10 billion to 20 billion, the bacterial count range of Bifidobacterium longum KMH001 is 5 billion to 10 billion, the bacterial count range of Bifidobacterium longum BR-108 is 1 billion to 2 billion (i.e., the bacterial count range of Bifidobacterium longum is 6 billion to 12 billion), and the bacterial count range of Lactobacillus helveticus MCC1848 is 500 million to 1 billion. However, the present invention is not limited to the above examples.

[0030] In practical application, the formulation of the lactic acid bacteria powder 2 can be a formulation that effectively helps maintain digestive function, i.e., the formulation of the lactic acid bacteria powder 2 may further include at least one functional ingredient. Preferably, the at least one functional ingredient is at least one of fructooligosaccharides, inulin (chicory fiber), corn starch, maltodextrin, calcium stearate, and silicon dioxide. Here, fructooligosaccharides are healthy oligosaccharides, and inulin is a water-soluble dietary fiber. Both are prebiotics that help create an environment for beneficial bacterial flora. In this embodiment, the dosage range of fructooligosaccharides is 530 mg (milligrams) to 1060 mg.

[0031] Of the five specific bacterial strains in this embodiment, three—Lactobacillus crispatus KT-11, Bifidobacterium longum KMH001, and Bifidobacterium longum BR-108—are derived from naturally occurring beneficial bacteria in the human intestine, making them more compatible with the human body. Lactobacillus crispatus KT-11 belongs to the "protective lactic acid bacteria" family and helps regulate the body to adapt to seasonal changes. Bifidobacterium longum KMH001 can maintain digestive health and relieve constipation. Bifidobacterium longum BR-108 can maintain smooth digestion and gently protect health. Lacticaseibacillus paracasei K-2 is derived from sake lees and has the effect of enhancing the body's protective power and adjusting physical constitution, while Lactobacillus helveticus MCC1848 is widely used in various foods and can effectively protect health and stabilize mood.

[0032] [Advantageous Effects of the Embodiments] Overall, the lactic acid bacteria powder packaged product of the present invention is lightweight, space-saving, and portable, and the lactic acid bacteria powder can be taken by simply breaking one of the seals on the packaging bag.Furthermore, the lactic acid bacteria powder packaged product of the present invention has significant effects on improving digestion, maintaining the balance of beneficial intestinal flora, and promoting human health.

[0033] The lactic acid bacteria powder formulation includes Lacticaceae Bacillus paracasei, Bifidobacterium longum, Lactobacillus crispatus, and Lactobacillus helveticus. The combination of specific strains creates a synergistic effect, stabilizing the balance of intestinal flora and maintaining good digestive function.

[0034] To further explain, the lactic acid bacteria powder formulation may further comprise at least one functional ingredient. The at least one functional ingredient may be at least one of fructooligosaccharides, inulin (chicory fiber), corn starch, maltodextrin, calcium stearate, and silicon dioxide. Here, fructooligosaccharides are healthy oligosaccharides, and inulin is a water-soluble dietary fiber. Both are prebiotics that help create an environment for beneficial flora.

[0035] To explain further, the lactic acid bacteria powder may be heat-treated lactic acid bacteria powder. Lactic acid bacteria that have been inactivated by heat (heat-treated lactic acid bacteria) have improved heat resistance, so there is no need to worry about the number of bacteria decreasing even if the water temperature is relatively high, and they are not easily decomposed by gastric acid, so after being digested by gastric acid, they can reach the intestines and function stably.

[0036] The above disclosure is merely a preferred embodiment of the present invention, and the scope of the claims of the present invention is not limited thereto. Therefore, any equivalent technical modifications made by using the contents of the specification and drawings of the present invention are included in the scope of the claims of the present invention. [Explanation of symbols]

[0037] Z...Lactic acid bacteria powder packaging products 1...Packaging bag 100...Closed space 11,12...Seal structure 11'...Spout 11L...Tear Line 2. Lactic acid bacteria powder 111...outer layer 112...Middle class 113...inner layer

Claims

1. Packaging bag and lactic acid bacteria powder included, The packaging bag has two seal structures and a closed space located between the two seal structures, A lactic acid bacteria powder packaged product, characterized in that the lactic acid bacteria powder is contained in the closed space.

2. 2. The lactic acid bacteria powder packaged product according to claim 1, wherein the lactic acid bacteria powder blend comprises Lacticaceibacillus paracasei, Bifidobacterium longum, Lactobacillus crispatus, and Lactobacillus helveticus.

3. The lactic acid bacteria powder packaged product according to claim 1, wherein the number of bacteria in the lactic acid bacteria powder ranges from 100 billion to 200 billion.

4. The lactic acid bacteria powder packaged product according to claim 1, wherein the dosage range of the lactic acid bacteria powder is 1.5 g to 3 g.

5. The lactic acid bacteria powder packaged product according to claim 2 , wherein the blend of lactic acid bacteria powder is heat-treated lactic acid bacteria powder.

6. 3. The lactic acid bacteria powder packaged product according to claim 2, wherein the range of bacterial count of the Lacticaceibacillus paracasei is 100 billion to 200 billion, the range of bacterial count of the Bifidobacterium longum is 6 billion to 12 billion, the range of bacterial count of the Lactobacillus crispatus is 10 billion to 20 billion, and the range of bacterial count of the Lactobacillus helveticus is 500 million to 1 billion.

7. The lactic acid bacteria powder packaged product according to claim 2, wherein the blend of the lactic acid bacteria powder includes at least one functional ingredient.

8. The lactic acid bacteria powder packaged product according to claim 7, wherein the at least one functional ingredient is at least one of fructooligosaccharide, inulin, corn starch, maltodextrin, calcium stearate, and silicon dioxide.

9. The lactic acid bacteria powder packaged product according to claim 8, wherein the dosage range of the fructooligosaccharide is 530 mg to 1060 mg.

10. The lactic acid bacteria powder packaged product according to claim 1, wherein the packaging bag is a stick packaging bag.

11. The lactic acid bacteria powder packaged product according to claim 1, wherein one of the two seal structures has a tear line.

12. The lactic acid bacteria powder packaged product according to claim 1, wherein the packaging bag is formed of an aluminum foil composite structure.

13. The lactic acid bacteria powder packaging product according to claim 12, wherein the aluminum foil composite structure comprises an outer layer, an inner layer, and an intermediate layer located between the outer layer and the inner layer, and the material of the intermediate layer is aluminum foil.

Images